Patents for A61P 33 - Antiparasitic agents (21,787)
01/1999
01/07/1999EP0889126A2 YNL075W/HTXFT19 polypeptide
01/07/1999EP0888352A1 Fused imidazole derivatives as multidrug resistance modulators
01/07/1999EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases
01/06/1999CN1204335A 4a,5a,8a,8b-tetrahydro-6H-pyrrolo [3',4' : 4,5] furo (3,2-b] pyridine-6,8 [7H]-dione derivatives for use in controlling endoparasites and method
01/06/1999CN1204261A Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroxy-fatty acid
01/05/1999US5856526 Comminution; solvent extraction
01/05/1999US5856324 Use of dioxomorpholines for combat endoparasites, dioxomorpholines and process for their production
01/05/1999US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
01/02/1999CA2221861A1 Ynl075w/htxft19
12/1998
12/30/1998EP0887415A2 Human RCE1
12/30/1998EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor
12/30/1998EP0886654A1 Thioureido-cyclodextrins particularly useful for solubilising antitumoral and antiparasitic agents, and methods for preparing same
12/30/1998CN1203078A Process for preparing synergetic antimalarial-compound naphthoquine phosphate
12/29/1998US5854289 Guanylhydrazones and their use to treat inflammatory conditions
12/29/1998US5854051 Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof
12/29/1998US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998057976A1 Secreted proteins and polynucleotides encoding them
12/23/1998WO1998057969A1 4-haloalkyl-3- heterocyclylpyridines and 4-haloalkyl -5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides
12/23/1998EP0885233A1 Terpyridine-platinum(ii) complexes
12/23/1998EP0885012A1 Malaria vaccine based upon the addition of a msa1 peptide
12/23/1998EP0541629B1 Cloning and expression of a rhoptry associated protein of (p.falciparum)
12/23/1998CN1202493A Intermediate of doramectin for antiparastic chemical and its preparing method
12/23/1998CN1202367A Use of basket fern effective parts in preparing antimalarial drug
12/23/1998CA2294888A1 4-haloalkyl-3- heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyrimidines, processes for their preparation, compositions comprising them, and their use as pesticides
12/23/1998CA2294569A1 Secreted proteins and polynucleotides encoding them
12/17/1998WO1998057176A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents
12/17/1998WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056802A1 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
12/17/1998WO1998056801A1 C-4''-substituted macrolide derivatives
12/17/1998WO1998056800A1 9-oxime erythromycin derivatives
12/17/1998WO1998056414A1 Oil in water vaccine compositions
12/17/1998WO1998056390A1 Anthelmintic compositions
12/17/1998WO1998056383A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998WO1998040401A3 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
12/17/1998DE19725450A1 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclylpyrimidine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel 4-haloalkyl-3-heterocyclylpyridine and 4-haloalkyl-5-heterocyclylpyrimidine, processes for their preparation, compositions containing them and their use as pesticides
12/17/1998CA2295704A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998CA2293683A1 Anthelmintic compositions
12/17/1998CA2293444A1 Oil in water vaccine compositions
12/17/1998CA2293335A1 9-oxime erythromycin derivatives
12/17/1998CA2291653A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents
12/16/1998CN1202155A Antimalarial quinolin derivatives
12/15/1998US5849794 Guanylhydrazones and their use to treat inflammatory conditions
12/15/1998US5849691 Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
12/15/1998US5849306 Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055622A1 Preparation of glycosylated tumor necrosis factor
12/10/1998WO1998055469A1 Desoxycyclodepsipeptides and their use for combatting endoparasites
12/10/1998WO1998055449A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
12/10/1998WO1998040497A3 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
12/10/1998CA2292698A1 Desoxycyclodepsipeptides and their use for combatting endoparasites
12/10/1998CA2289564A1 Preparation of glycosylated tumor necrosis factor
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882060A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof
12/09/1998EP0881881A1 Antiparasitic composition for treating and protecting pets
12/09/1998EP0745089B1 Antiparasitic agents
12/08/1998US5847092 Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity
12/08/1998US5846545 Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
12/08/1998US5846540 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
12/08/1998US5846527 Continuous cell line and vaccine against avian coccidia
12/03/1998WO1998054170A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNFα LEVELS
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/02/1998EP0880589A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
12/02/1998EP0880588A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5843722 Coccidiosis poultry vaccine
11/1998
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/25/1998EP0606380B1 2-substituted quinolines for treating leishmanioses
11/24/1998US5840911 Imidazole derivatives, their preparation and their use as S-adenosylmethionine decarboxylase (=SAMDC) inhibitors
11/24/1998US5840700 Methods of producing transfer factor
11/19/1998WO1998051688A1 6-SUBSTITUTED 1,2,4a,5a,8a,8b HEXAHYDRO- AND 1,2,3,4,4a,5a,8a,8b-OCTAHYDRO-6H-PYRROLO [3',4':4,5]FURO[3,2-b]PYRID-8(7H)-ON DERIVATIVES AND THEIR USE IN COMBATTING ENDOPARASITES
11/19/1998DE19719839A1 6-Substituierte 1,2,4a,5a,8a,8b-Hexahydro- und 1,2,3,4,4a,5a,8a,8b-Oktahydro-6H-pyrrolo/3',4':4,5/furo/3,2-b/pyrid-8(7H)-on Derivate und ihre Verwendung zur Bekämpfung von Endoparasiten 6-Substituted 1,2,4a, 5a, 8a, 8b-hexahydro- and 1,2,3,4,4a, 5a, 8a, 8b-octahydro-6H-pyrrolo / 3 ', 4': 4,5 / furo / 3,2-b / pyrid-8 (7H) -one derivatives and their use for controlling endoparasites
11/19/1998CA2289450A1 6-substituted 1,2,4a,5a,8a,8b hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6h-pyrrolo [3',4':4,5]furo[3,2-b]pyrid-8(7h)-on derivatives and their use in combatting endoparasites
11/18/1998EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998EP0878192A2 Method for treating protozoal infections
11/18/1998EP0877809A1 TOXOPLASMA GONDII ANTIGEN Tg20
11/18/1998CN1199395A Process for preparation of anti-malarial drugs
11/18/1998CN1199394A Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing same
11/17/1998US5837734 Method for the treatment of coccidioidomycosis in warm-blooded animals
11/17/1998US5837228 Drug delivery device for controlled release of drugs
11/12/1998WO1998050035A1 Pharmaceutical compositions of tizoxanide and nitazoxanide
11/11/1998EP0876387A1 Method to improve the biological and antiviral activity of protease inhibitors
11/11/1998EP0876346A1 Antimalarial quinolin derivatives
11/11/1998EP0876156A1 Compositions and methods for administering borrelia burgdorferi antigens
11/11/1998EP0876153A2 Medical use of proteases
11/11/1998EP0739344B1 Antiparasitic pyrrolobenzoxazine compounds
11/11/1998CN1198669A Use of aminoadamantane compound as immunoregulators
11/11/1998CN1198330A Method for treating protozoal infections
11/10/1998US5834505 Antimalarial drugs
11/10/1998US5834491 Bis(2-aminopyridine)s, preparation method therefor and use thereof for controlling parasitic infections
11/10/1998US5834486 Antiproliferative, antiprotozoa agents
11/10/1998US5834260 Antiparasitic agents
11/10/1998US5834015 Protein-lipid vesicles and autogenous vaccine comprising the same
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049311A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
11/05/1998WO1998049303A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases
11/05/1998CA2288433A1 Compositions and methods for conferring tick immunity and preventing tick borne diseases
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)